← Sectoral/ Thematic

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Nippon India
Sectoral/ Thematic
Current NAV
543.97
in-form

Rating Analysis

This fund is significantly outperforming its category average, generating strong alpha.

1Y Alpha
-1.2%
vs cat avg 4.8%
3Y Alpha
+6.1%
vs cat avg 18.1%
5Y Alpha
+1.4%
vs cat avg 15.2%

Returns

1Y Return
+3.6%
Category 4.8%
3Y Return
+24.2%
Category 18.1%
5Y Return
+16.6%
Category 15.2%

NAV History (1 Year)

Add to Compare →